Komaba Junji, Hosogi Jun, Igarashi Harue, Kamimori Hiroshi, Nakai Keiko, Nakamura Takahiro, Kawai Yosuke, Sano Yoshihisa, Yamaguchi Takeru
Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd, Tsukuba, Ibaraki, Japan.
Translational Research Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd, Nagaizumi, Shizuoka, Japan.
Bioanalysis. 2018 Sep 1;10(18):1467-1471. doi: 10.4155/bio-2018-0198. Epub 2018 Sep 10.
The ninth Japan Bioanalysis Forum symposium took place at tower hall Funabori, Tokyo, Japan, between 6 and 8 February, 2018. Bioanalytical scientists from the pharmaceutical industry, CROs, academia and regulatory bodies had many meaningful and relevant discussions on current topics of interest in bioanalysis. The 3-day symposium featured updated perspectives and experiences on regulated bioanalysis of small and large molecules, biomarker measurement and assessment of immunogenicity, as well as new areas of bioanalytical validation such as quantitative polymerase chain reaction(qPCR) and flow cytometry. There were over 260 participants from six countries, with 23 oral and 11 poster presentations, including the outcomes of Japan Bioanalysis Forum discussion groups. This report summarizes the major discussion topics from the conference.
第九届日本生物分析论坛研讨会于2018年2月6日至8日在日本东京船堀塔楼大厅举行。来自制药行业、合同研究组织、学术界和监管机构的生物分析科学家就生物分析领域当前感兴趣的话题进行了许多有意义且相关的讨论。为期3天的研讨会展示了小分子和大分子的规范生物分析、生物标志物测量和免疫原性评估的最新观点和经验，以及生物分析验证的新领域。来自六个国家的260多名参与者参加了此次研讨会，会上进行了23场口头报告和11场海报展示，其中包括日本生物分析论坛讨论小组的成果。本报告总结了会议的主要讨论主题。
